Abstract Body

Background

The mechanisms underlying latent HIV reservoir establishment and maintenance remain poorly understood and a hinderance to an HIV cure. Elevated plasma levels of galectin-9 (Gal-9), a β-galactoside-binding lectin, predicts slower intact proviral DNA decay in people with HIV (PWH) on antiretroviral therapy (ART) and associates with increased gut mucosal SIV burden. Here, we investigated mechanisms underlying Gal-9-mediated reservoir establishment and expansion, and assessed the potential of P4D2, an anti-Gal-9 monoclonal antibody (mAb), to target HIV persistence.

Methods

Primary CD4+ T cells isolated from people without HIV were treated with exogenous recombinant Gal-9 or co-cultured with HEK-293T cells engineered to overexpress endogenous Gal-9 using CRISPR activation. Pretreated cells were then infected with HIV-1 NL4-3 or BaL. Levels of total and phosphorylated SAMHD1 protein (restriction factor that blocks HIV infection of resting cells by preventing reverse transcription) and TRIM21 (SAMHD1 regulator) were measured by western blot and flow cytometry. A panel of pathway inhibitors was applied to characterize Gal-9 signaling. HIV reverse transcripts and integrated DNA were quantified by qRT-PCR. CD4+ T cell subset distribution and proliferation (Ki-67 expression and CFSE dilution) were assessed by flow cytometry. Primary CD4+ T cells from PWH on ART (n=3) were treated with Gal-9, and HIV proviral DNA was quantified by digital PCR.

Results

Both exogenous and endogenous Gal-9 enhanced HIV infection of resting CD4+ T cells (p<0.05) (Fig.1A). Gal-9 induced SAMHD1 phosphorylation (p<0.0001) and downregulated SAMHD1 (p<0.01) via TRIM21 induction (p<0.001) (Fig.1B), leading to increased HIV reverse transcription (p<0.05) and proviral integration (p<0.0001). P4D2 abrogated these effects (p<0.05). Inhibition of CD45 and JAK signaling pathways prevented Gal-9-mediated SAMHD1 deactivation (p<0.01). Gal-9 promoted CD4+ T cell proliferation (p<0.01) and expanded the stem cell-like memory T cell compartment, which was preferentially infected by HIV in the presence of Gal-9 (p<0.001). Gal-9 increased HIV proviral DNA frequencies in CD4+ T cells from PWH on ART (p<0.01). 

Conclusions

Gal-9 promotes establishment and expansion of a self-renewing HIV reservoir by facilitating infection and proliferation of stem cell-like CD4+ T cells. Signaling via CD45 and JAK mediates these Gal-9 effects. The P4D2 mAb shows potential as a therapeutic strategy to prevent Gal-9-mediated enhancement of HIV persistence.

Table or Figure